SRTOY (Sartorius Stedim Biotech) 5-Year EBITDA Growth Rate : 25.10% (As of Sep. 2024)

View and export this data going back to 2019. Start your Free Trial

What is Sartorius Stedim Biotech 5-Year EBITDA Growth Rate?

Sartorius Stedim Biotech's EBITDA per Share for the three months ended in Sep. 2024 was $0.17.

During the past 12 months, Sartorius Stedim Biotech's average EBITDA Per Share Growth Rate was -46.50% per year. During the past 3 years, the average EBITDA Per Share Growth Rate was 9.90% per year. During the past 5 years, the average EBITDA Per Share Growth Rate was 25.10% per year. During the past 10 years, the average EBITDA Per Share Growth Rate was 23.80% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

During the past 13 years, the highest 3-Year average EBITDA Per Share Growth Rate of Sartorius Stedim Biotech was 49.90% per year. The lowest was 0.80% per year. And the median was 22.00% per year.

Competitive Comparison of Sartorius Stedim Biotech's 5-Year EBITDA Growth Rate

For the Medical Instruments & Supplies subindustry, Sartorius Stedim Biotech's 5-Year EBITDA Growth Rate, along with its competitors' market caps and 5-Year EBITDA Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Sartorius Stedim Biotech's 5-Year EBITDA Growth Rate Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Sartorius Stedim Biotech's 5-Year EBITDA Growth Rate distribution charts can be found below:

* The bar in red indicates where Sartorius Stedim Biotech's 5-Year EBITDA Growth Rate falls into.

Sartorius Stedim Biotech 5-Year EBITDA Growth Rate Calculation

This is the 5-year average growth rate of EBITDA per Share. The growth rate is calculated with least square regression.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

Sartorius Stedim Biotech (OTCPK:SRTOY) 5-Year EBITDA Growth Rate Explanation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.

5-Year EBITDA Growth Rate gives an overview of the company's growth in operating profitability and is an important factor used in calculating Peter Lynch Fair Value.

Sartorius Stedim Biotech 5-Year EBITDA Growth Rate Related Terms

Thank you for viewing the detailed overview of Sartorius Stedim Biotech's 5-Year EBITDA Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

Sartorius Stedim Biotech Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Sartorius Stedim Biotech SA (OTCPK:SRTOY) » Definitions » 5-Year EBITDA Growth Rate

Comparable Companies

Traded in Other Exchanges

SDMHF:USA DIMp:UK 0RG8:UK DIM:France 56S1:Germany 56S1:Germany 56S1:Germany DIM:Austria

Address

Otto-Brenner-Strasse 20, Goettingen, DEU, 37079

Website

https://www.sartorius.com

Sartorius Stedim Biotech, or SSB, is a leading provider of bioprocessing solutions. Its sells equipment and consumables for fermentation, filtration, fluid management, purification, and cell culture media for manufacturing biologic drugs, and has a focus on single-use technology, or SUT. It is a subsidiary of Sartorius AG, which has a 74% ownership and 85% voting control. The business is geographically diverse.